MedPath

A study for the effect of the intake of an aojiru beverage on microflora

Not Applicable
Conditions
rough skin, dry skin
Registration Number
JPRN-UMIN000025249
Lead Sponsor
TOYO SHINYAKU Co., Ltd.
Brief Summary

Continual YBLP(Young barley leaf powder) ingestion tended to increase a beneficial bacterium, and decrease unhealthy bacteria in gut microbiome.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects who take antibiotics within the last two months prior to the current study or who take intestinal drugs daily 2.Subjects who are under treatment by a dermatologist for dry skin, inflammation or other skin diseases. Or difficulty with measuring points by scars or other skin problems 3.Subjects who are serious constipated or contract serious diseases of anus or intestines 4.Subjects who contract diseases which may affect the current study 5.Subjects who are menstrual irregularity (except for menopause) 6.Subjects who take other aojiru, foods which influence intestinal functions, supplements, other specified foods daily, and they are not able to stop during the current study period 7.Subjects who have declared allergic reaction to test foods 8.Subjects who are under treatment for or have a history of drug addiction or alcoholism 9.Subjects who are pregnant or are planning to become pregnant after informed consent for the current study 10.Subjects who are planning to participate and/or are participating in other clinical studies 11.Subjects who are judged as unsuitable for the current study by the investigator for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of skin conditions (measurement time: 0,4,8 weeks after ingestion of the test bevarage) Measurement of microflora (measurement time: 0,8 weeks after ingestion of the test bevarage)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath